12/17/2024
5:04 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2024
4:02 PM | Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
4:07 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
4:16 PM | Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
3:44 PM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
3:35 PM | Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:46 PM | Ascendis Pharma A/S (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
|
11/14/2024
1:57 PM | Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/14/2024
8:31 AM | Ascendis Pharma A/S (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:02 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024
8:51 AM | Artisan Partners Limited Partnership (Filed by)
Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
11/08/2024
9:34 AM | Ascendis Pharma A/S (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/04/2024
6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024
7:35 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024
3:59 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
4:20 PM | Ascendis Pharma A/S (Filer)
| Form 424B5 | |
09/18/2024
3:01 PM | Ascendis Pharma A/S (Filer)
| Form F-3ASR | |
09/16/2024
6:28 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
6:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024
3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:10 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:11 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:14 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024
6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2024
5:07 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024
3:26 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
3:08 PM | Ascendis Pharma A/S (Filer)
| Form SD
Specialized Disclosure Report | |
05/14/2024
1:37 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024
8:16 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
10:31 AM | Ascendis Pharma A/S (Subject)
Bodenhoff Mads (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
8:39 PM | Ascendis Pharma A/S (Subject)
Fairey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
8:47 AM | Ascendis Pharma A/S (Subject)
Cha Albert (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
7:04 AM | Ascendis Pharma A/S (Subject)
SPROGOE KENNETT (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
7:14 AM | Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:52 AM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:37 AM | Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
1:54 PM | Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
2:07 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
2:17 PM | Ascendis Pharma A/S (Subject)
RASMUSSEN PETER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
1:36 PM | Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
1:24 PM | Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad) You don’t actually want to buy Bitcoin this time around.
That’s because there’s a better way to take advantage of this new bull market…
One market expert calls it Crypto’s Hidden Gem
And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin…
That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky…
This is a much safer and better approach to ride this years’ crypto bull run.
Because believe it or not…
The 2024 crypto bull run is one you DON’T want to miss. Click Here to get the full details about Crypto’s Hidden Gem |
03/01/2024
10:00 AM | Ascendis Pharma A/S (Subject)
HOLTUG LARS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:13 PM | Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:21 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024
5:17 PM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
4:45 PM | Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:17 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
4:14 PM | Ascendis Pharma A/S (Subject)
Volck Birgitte (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
4:15 PM | Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
4:16 PM | Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
10:40 AM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
8:17 AM | Ascendis Pharma A/S (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
10:57 AM | Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/12/2024
5:12 AM | Artisan Partners Limited Partnership (Filed by)
Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
02/09/2024
1:17 PM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
7:35 AM | Ascendis Pharma A/S (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
3:15 PM | Ascendis Pharma A/S (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
02/02/2024
12:18 PM | Ascendis Pharma A/S (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SC 13G/A | |
01/29/2024
7:36 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
5:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
5:08 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2024
5:08 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Free ASND Stock Alerts